Haleon (LON:HLN) Stock Price Down 0.2% – Here’s What Happened

Haleon plc (LON:HLN)’s stock price traded down 0.2% during trading on Monday . The company traded as low as GBX 373.90 ($4.68) and last traded at GBX 376.90 ($4.72). 24,362,850 shares were traded during trading, an increase of 88% from the average session volume of 12,988,258 shares. The stock had previously closed at GBX 377.63 ($4.72).

Haleon Stock Down 0.8 %

The firm has a market cap of £33.80 billion, a PE ratio of 3,115.83, a PEG ratio of 1.49 and a beta of 0.19. The company has a debt-to-equity ratio of 54.18, a quick ratio of 0.93 and a current ratio of 0.84. The company’s 50-day simple moving average is GBX 374.11 and its two-hundred day simple moving average is GBX 368.09.

Insider Transactions at Haleon

In other Haleon news, insider Dawn Allen sold 74,679 shares of the business’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of GBX 372 ($4.65), for a total transaction of £277,805.88 ($347,561.47). Also, insider Alan Stewart bought 33,923 shares of the company’s stock in a transaction dated Wednesday, November 6th. The stock was bought at an average cost of GBX 368 ($4.60) per share, with a total value of £124,836.64 ($156,182.46). 10.74% of the stock is currently owned by company insiders.

Haleon Company Profile

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.